Financial Writing and Equity Research

772-219-7525
Call Today!

Liberator Medical Holdings Inc. 
(NYSE MKT: LBMH)

Liberator Medical Supply Inc. is a wholly owned subsidiary of Liberator Medical Holdings Inc., (NYSE MKT: LBMH).   The Company offers over 5,000 products to Medicare-eligible patient populations with chronic conditions requiring repeat-orders of maintenance supplies. Direct billing to Medicare is a key component of the Company’s strategic plans, providing strong third-party payment revenue continuum, critical to funding the Company’s goals, as well as creating continued consumer purchase incentive due to ease and convenience.

The Company’s management team, led by founder CEO Mark Libratore, brings a unique competitive advantage to Liberator’s goals of rapid expansion into several of the healthcare market’s highest-opportunity growth segments. As creators of a marketing model that uses national Direct-to-Consumer advertising to fuel the growth of their former company, Liberty Medical Supply, into a super brand in the diabetes arena, Mr. Libratore and his team are recognized as innovative contributors to the growth of the U.S. medical supplies industry.

By executing their own marketing model to meet four of the highest growth opportunities of the industry--mastectomy, urology, ostomy and mobility patients –as well as diabetes— the Liberator brand is in a unique position to achieve market leadership and increased long-term value for its shareholders.

Quick Links

Investor Relations Presentation Fact Sheet Proxy
Statements
     
 

Share Statistics

Outstanding: 52.9 m

Investment Highlights

  • Proven Business Model and Management Team
  • A Consistent Track Record of Triple-Digit Revenue Growth
  • Strong Payor Sources Including Medicare, Medicaid, and Insurance Companies
  • Very High and Sustainable Gross Margins from 45% to over 70%
  • Market Size - Diagnosed 36.2 million - Undiagnosed 12 million - Current Market Size $99.4 billion

Company Information

Liberator Medical Holdings, Inc.
2979 SE Gran Park Way
Stuart, FL 34997

CEO: Mark Libratore

Issue Type: Common Stock
Sector: Health care
Industry: Medical Supplies

Accredited

Management Team

Mark Libratore
President, CEO

Robert Davis
CFO

John Leger
COO


Paul Levett
CMO

George Narr
CIO

Investor Relations Contact

Investor Relations
The WSR Group
Gerald Kieft
Email: LiberatorIR@wallstreetresources.net
Phone: (772) 219-7525

Institutional IR Contact
Bob Davis, CFO
Phone: (772) 463-3737
bdavis@liberatormedical.com

Transfer Agent

Jersey Transfer & Trust Company, Inc.
201 Bloomfield Avenue
Verona, NJ 07044

Independent Auditor

Crowe Horwath LLP

Clients

Liberator Medical Holdings, Inc.